Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research for Patient Benefit Programme - Competition 43 stage 2 and Competition 44 stage 1 minutes, South East & Central

Contents

Published: 03 August 2021

Version: 1.0 - May 2021

Print this document

Minutes for the Research for Patient Benefit (RfPB) programme South East and Central Advisory Committee meeting to discuss applications to Competition 43 Stage 2 and Competition 44 Stage 1.

Date and Location

Wednesday 19 May 2021 via online virtual meeting

In attendance

Committee Members

Professor Carrie Llewellyn (Chair)
Mrs Wendy Blunden
Professor Stephen Bremner
Dr Nadia Brookes
Professor Daniel Freeman
Ms Rosemary Greenwood
Dr Mark Hayward
Dr Christina Jones
Miss Alison Provins
Professor Najib M Rahman
Dr James Sheppard
Professor Ian Swaine
Mrs Ann-Marie Towers
Mr David Turner
Dr Dawn-Marie Walker
Mr Keith Wyncoll

Secretariat

Dr Laura Tornatore (NIHR CCF)
Dr Kasia Kuleszewicz (NIHR CCF)
Ms Lily Tomlinson (NIHR CCF)
Mr Marc Browne (NIHR CCF)
Professor Sue Ziebland (Programme Director)
Ms Thembi Huna (NIHR CCF)

Observers 

Dr Elaine Kingwell RDS - LDN
Dr Beki Langford RDS - SW

Stage 2 Applications considered

NIHR202826 

Improving testing for cardiometabolic diseases in women with previous gestational diabetes mellitus: an exemplar study on implementation and evaluation of a novel data driven randomised clinical trial platform in primary care
Conflicts: Ms Rosemary Greenwood and Dr James Sheppard
Final outcome: Conditional support

NIHR202784 

GUISE (GUIdance and SElf-management): A feasibility study to investigate, before going to full trial, the acceptability of an intervention designed to empower patients with the knowledge and understanding of the causes, consequences and prevention of metabolic associated fatty liver disease (MAFLD) to support lifestyle change
Conflicts: Professor Ian Swaine, Mr David Turner and Dr Dawn-Marie Walker
Final outcome: Reject

NIHR202733 

Maximising Mobility and Strength Training (MMOST) Feasibility Trial
Conflicts: Professor Stephen Bremner, Professor Najib Rahman and Dr James Sheppard
Final outcome: Conditional support

NIHR202821

Improving vision assessments in patients with inherited eye disease
Conflicts: Professor Najib Rahman  
Final outcome: Conditional support

NIHR202770

E-Cigarettes as an Alternative to Smoking for people living with HIV (EC-ASH): A mixed methods feasibility study
Conflicts: Professor Stephen Bremner and Professor Carrie Llewellyn. Dr Mark Hayward chaired the discussion.
Outcome: Reject

Stage 1 Applications considered

NIHR203047

Feasibility of a pain management intervention to improve recovery after major trauma: the PROMOTE study
Conflicts: Professor Stephen Bremner, Professor Daniel Freeman and Professor Najib Rahman 
Outcome: Invite to Stage 2

NIHR203178

Development of a Resource for Healthcare Professionals to Facilitate Family-centred Conversations when an Adult Patient has a Life-threatening Condition
Conflicts: Professor Daniel Freeman and Professor Najib Rahman
Outcome: Invite to Stage 2 

NIHR203127

World Hip Trauma Evaluation - DeCI: Delirium and Cognitive Impairment
Conflicts: None
Outcome:
Reject

NIHR203177

Technology to Improve Burn care for Young people (TIBY)
Conflicts: None 
Outcome:
Reject

NIHR203185 

"ExACT-CF: Exercise as Airway Clearance Therapy in people with cystic fibrosis – A feasibility trial"
Conflicts: Mr David Turner
Outcome:
Invite to Stage 2 

NIHR203090

Vaccination in people with Intellectual Disabilities; understanding, attitudes and access
Conflicts: Ms Nadia Brookes, Professor Ian Swaine, Mrs Ann-Marie Towers, Mr David Turner and Mr Keith Wyncoll
Outcome: Reject

NIHR203071

Cultural sector interventions to improve the wellbeing of people with mild cognitive impairment, offered through social prescribing
Conflicts: Professor Daniel Freeman and Dr James Sheppard 
Outcome: Reject

NIHR203120

Informing patients about the long-term issues facing cancer survivors: Data derived from the Add-Aspirin clinical trial
Conflicts: Professor Carrie Llewellyn. Professor Daniel Freeman chaired the discussion.
Outcome:
Reject

NIHR203167 

Joint Decision Initiative: Development and testing of three new decision aids for shared decision-making in orthopaedics
Conflicts: Professor Najib Rahman
Outcome: Reject

NIHR203222 

Implementing and evaluating the trained palliative care volunteer role in hospice settings: a feasibility study of a stepped wedge trial
Conflicts: Ms Nadia Brookes, Professor Ian Swaine and Mrs Ann-Marie Towers
Outcome: Reject

NIHR203202

Home monitoring of vital signs to detect exacerbations in cystic fibrosis and chronic obstructive pulmonary disease: a feasibility study
Conflicts: Professor Stephen Bremner, Dr Christina Jones and Mr David Turner
Outcome: Reject

Outcomes tables

The tables below display the mean score for each application that was assessed in the regional assessment committee meeting, and excludes applications which were rejected during the scrutiny and triage processes. The number of applications receiving each mean score are listed. The RfPB fundable range is 6-10, although a score of 6-10 does not guarantee funding or an invitation to Stage 2. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.

In exceptional circumstances, applications which fall below the fundable range may be invited to Stage 2 or recommended for funding by the Committee. The Programme Director reviews in detail any applications recommended for funding with a score below 7.

Stage 1

ScoreRangeNumber of applications
9-10 Invited 0
8 Invited
7 Invited 2
6 Invited 2
5 Rejected 6
4 Rejected 1
3 Rejected 0
2 Rejected 0
1 Rejected 0

 

Stage 2

ScoreRangeNumber of applications
9-10 Fundable 0
8 Fundable 1
7 Fundable 1
6 Fundable 1
5 Rejected 1
4 Rejected 1
3 Rejected 0
2 Rejected 0
1 Rejected 0